Excited that the results of the phase I/II trial of modakafusp alfa in patients with relapsed/refractory multiple myeloma are now published in @bloodjournal.bsky.social. This agent has a novel mechanism of action and has single-agent activity.
#mmsm
#mmsm
Comments